Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 2/20 | 0.53 |
| ▸ | LGALS8 | O00214 | 8/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.38 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25505005 | 1.00 | FGF1 (0.53) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL27704275 | 0.85 | LGALS8 (0.41) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL1893622 | 0.84 | FGF1 (0.51) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL14641263 | 0.84 | FGF1 (0.51) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL27702121 | 0.83 | LGALS8 (0.41) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL2243493 | 0.83 | LGALS8 (0.41) | FGF1LGALS8CA1CA2CA9 | |
| SCHEMBL10781125 | 0.82 | LGALS8 (0.57) | FGF1LGALS8LGALS3 | |
| SCHEMBL14010636 | 0.82 | LGALS8 (0.57) | FGF1LGALS8LGALS3 | |
| SCHEMBL15095565 | 0.82 | LGALS8 (0.57) | FGF1LGALS8LGALS3 | |
| SCHEMBL10781121 | 0.82 | LGALS8 (0.57) | FGF1LGALS8LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |